Novo Nordisk launches a $499 monthly plan for Ozempic to help U.S. patients struggling with high out-of-pocket drug costs. Novo Nordisk, the global pharmaceutical giant behind the popular diabetes and weight-loss drug
Real estate investment in 2025 is driven by sustainability, technology, and new opportunities from co-living to digital real estate. The real estate market in
Talks stall as Kinshasa and M23 rebels remain divided on disarmament and political guarantees. The Democratic Republic of Congo’s long-running conflict took another uncertain turn as the government and M23 rebels failed